within Pharmacolibrary.Drugs.ATC.D;

model D11AX05
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1,
    Cl             = 0.08,
    adminDuration  = 600,
    adminMass      = 4.0,
    adminCount     = 1,
    Vd             = 0.00025,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0,
    Tlag           = 0
  );

  annotation(Documentation(
    info ="<html><body><p>Magnesium sulfate is an inorganic salt used primarily for its anticonvulsant properties in eclampsia and pre-eclampsia, as a tocolytic agent in preterm labor, and as a replacement therapy for hypomagnesemia. It is also used intravenously or intramuscularly for the management of arrhythmias and severe asthma exacerbations. Approved for medical use, especially in obstetric and emergency medicine settings.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in adult patients (including pregnant women) following intravenous administration; typically referenced from published population PK studies in critically ill patients.</p><h4>References</h4><ol><li><p>Lu, JF, &amp; Nightingale, CH (2000). Magnesium sulfate in eclampsia and pre-eclampsia: pharmacokinetic principles. <i>Clinical pharmacokinetics</i> 38(4) 305–314. DOI:<a href=&quot;https://doi.org/10.2165/00003088-200038040-00002&quot;>10.2165/00003088-200038040-00002</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/10803454/&quot;>https://pubmed.ncbi.nlm.nih.gov/10803454</a></p></li><li><p>Rower, JE, et al., &amp; Finkelstein, Y (2025). Pharmacokinetics and Pharmacodynamics of Intravenous Magnesium Sulfate in Pediatric Acute Asthma Exacerbations. <i>Journal of clinical pharmacology</i> 65(6) 665–674. DOI:<a href=&quot;https://doi.org/10.1002/jcph.6179&quot;>10.1002/jcph.6179</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/39775569/&quot;>https://pubmed.ncbi.nlm.nih.gov/39775569</a></p></li><li><p>Brookfield, K, et al., &amp; Carvalho, B (2021). Magnesium sulfate pharmacokinetics after intramuscular dosing in women with preeclampsia. <i>AJOG global reports</i> 1(4) 100018–None. DOI:<a href=&quot;https://doi.org/10.1016/j.xagr.2021.100018&quot;>10.1016/j.xagr.2021.100018</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/36277458/&quot;>https://pubmed.ncbi.nlm.nih.gov/36277458</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end D11AX05;
